Skip to main content

MoneyWorks4Me

Transgene Biotek - Quaterly Results

14 Nov 2026 Evaluate
The company witnessed a 13.21% growth in the revenue at Rs. 0.60 millions for the quarter ended September 2026 as compared to Rs. 0.53 millions during the year-ago period.The Net Loss for the quarter ended September 2026 is Rs. -3.46 millions as compared to Net Loss of Rs. -3.88 millions of corresponding quarter ended September 2025 Operating profit Margin for the quarter ended September 2026 improved to -0.15% as compared to -0.74% of corresponding quarter ended September 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 0.60 0.53 13.21 1.20 1.03 16.50 2.11 2.61 -19.16
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 1.50 7.84 -80.87
PBIDT -0.15 -0.74 -79.73 -0.73 -2.12 -65.57 -3.93 -3.40 15.59
Interest 2.90 2.64 9.85 5.80 5.10 13.73 10.60 2.43 336.21
PBDT -3.05 -3.38 -9.76 -6.53 -7.22 -9.56 -14.53 -5.83 149.23
Depreciation 0.41 0.50 -18.00 0.82 1.00 -18.00 1.99 0.93 113.98
PBT -3.46 -3.88 -10.82 -7.35 -8.22 -10.58 -16.52 -6.76 144.38
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -3.46 -3.88 -10.82 -7.35 -8.22 -10.58 -16.52 -6.76 144.38
Equity 757.70 757.70 0.00 757.70 757.70 0.00 757.70 757.70 0.00
PBIDTM(%) -25.00 -139.62 -82.09 -60.83 -205.83 -70.44 -186.26 -130.27 42.98
Peers
Company Name CMP
Sagility 44.86
Prime Focus 279.00
Indegene 648.35
Syngene Internatl. 431.15
Knowledge RealtyTrt. 111.99
View more..